鉄キレート薬の世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2022)

GlobalInfoResearchが発行した調査報告書(GIR71003369)
◆英語タイトル:Global Iron Chelation Drug Market by Manufacturers, Countries, Type and Application, Forecast to 2022
◆商品コード:GIR71003369
◆発行会社(リサーチ会社):GlobalInfoResearch
◆発行日:2017年8月17日
◆ページ数:116
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:化学・材料
◆販売価格オプション(消費税別)
Single UserUSD3,480 ⇒換算¥393,240見積依頼/購入/質問フォーム
Corporate UserUSD4,680 ⇒換算¥528,840見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalInfoResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートでは、鉄キレート薬の世界市場について調査・分析し、鉄キレート薬の世界市場概観、メーカー動向、メーカー別鉄キレート薬シェア、市場規模推移、市場規模予測、鉄キレート薬種類別分析(デフェロキサミン、デフェリプロン、デフェラシロクス)、鉄キレート薬用途別分析(輸血鉄過剰症、輸血非依存性サラセミア(NTDT)による鉄過剰症)、主要地域分析(北米、欧州、アジア)、主要国分析データなどを含め、以下の構成でお届け致します。
・鉄キレート薬の市場概観
・鉄キレート薬のメーカー概要(事業概要、製品種類、価格、売上、市場シェア等)
・鉄キレート薬のメーカー別販売動向、市場シェア、市場集中度、競争動向
・鉄キレート薬の世界市場規模
・鉄キレート薬の北米市場分析(アメリカ、カナダ、メキシコ等)
・鉄キレート薬のアメリカ市場規模推移
・鉄キレート薬のカナダ市場規模推移
・鉄キレート薬のメキシコ市場規模推移
・鉄キレート薬のヨーロッパ市場分析(ドイツ、イギリス、ロシア、フランス、イタリア等)
・鉄キレート薬のドイツ市場規模推移
・鉄キレート薬のイギリス市場規模推移
・鉄キレート薬のロシア市場規模推移
・鉄キレート薬のアジア市場分析(日本、中国、韓国、インド、東南アジア等)
・鉄キレート薬の日本市場規模推移
・鉄キレート薬の中国市場規模推移
・鉄キレート薬の韓国市場規模推移
・鉄キレート薬のインド市場規模推移
・鉄キレート薬の東南アジア市場規模推移
・鉄キレート薬の南米・中東・アフリカ市場分析
・鉄キレート薬の種類別分析/市場規模推移(デフェロキサミン、デフェリプロン、デフェラシロクス)
・鉄キレート薬の用途別分析/市場規模推移(輸血鉄過剰症、輸血非依存性サラセミア(NTDT)による鉄過剰症)
・鉄キレート薬の市場予測(地域別予測、種類別予測、用途別予測)
・鉄キレート薬の販売チャネル・代理店・貿易業者・ディーラー分析
【レポートの概要】

This report studies the Iron Chelation Drug market. The rationale behind using Iron chelation therapy is removing the increased iron burden specifically labile cell iron (LCI) to minimize production of reactive oxygen species (ROS) thereby decreasing cellular and organ damage. Patients most likely to benefit from chelation therapy include those with low or intermediate-1 IPSS risk MDS who have a long-life expectancy and are anticipated to receive more than 20 red blood cell transfusions and/or whose serum ferritin level is >1000 μg/L. Chelation therapy efficacy can be monitored by monitoring trends and levels of serum ferritin.

[Scope of the Report]
This report focuses on the Iron Chelation Drug in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Apotex Inc. (Canada)
Cipla (India)
Novartis (Switzerland)
Sun Pharma (India)
Natco Pharma (India)

Market Segment by Regions, regional analysis covers
North America (USA, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Columbia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Deferoxamine
Deferiprone
Deferasirox

Market Segment by Applications, can be divided into
Transfusional Iron Overload
NTDT Caused Iron Overload

There are 15 Chapters to deeply display the global Iron Chelation Drug market.

Chapter 1, to describe Iron Chelation Drug Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Iron Chelation Drug, with sales, revenue, and price of Iron Chelation Drug, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Iron Chelation Drug, for each region, from 2012 to 2017;

Chapter 5, 6, 7, 8 and 9, to analyze the key regions, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2012 to 2017;

Chapter 12, Iron Chelation Drug market forecast, by regions, type and application, with sales and revenue, from 2017 to 2022;

Chapter 13, 14 and 15, to describe Iron Chelation Drug sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

【レポートの目次】

Table of Contents

1 Market Overview
1.1 Iron Chelation Drug Introduction
1.2 Market Analysis by Type
1.2.1 Deferoxamine
1.2.2 Deferiprone
1.2.3 Deferasirox
1.3 Market Analysis by Applications
1.3.1 Transfusional Iron Overload
1.3.2 NTDT Caused Iron Overload
1.4 Market Analysis by Regions
1.4.1 North America (USA, Canada and Mexico)
1.4.1.1 USA Market States and Outlook (2012-2022)
1.4.1.2 Canada Market States and Outlook (2012-2022)
1.4.1.3 Mexico Market States and Outlook (2012-2022)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2012-2022)
1.4.2.2 France Market States and Outlook (2012-2022)
1.4.2.3 UK Market States and Outlook (2012-2022)
1.4.2.4 Russia Market States and Outlook (2012-2022)
1.4.2.5 Italy Market States and Outlook (2012-2022)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2012-2022)
1.4.3.2 Japan Market States and Outlook (2012-2022)
1.4.3.3 Korea Market States and Outlook (2012-2022)
1.4.3.4 India Market States and Outlook (2012-2022)
1.4.3.5 Southeast Asia Market States and Outlook (2012-2022)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2012-2022)
1.4.4.2 Egypt Market States and Outlook (2012-2022)
1.4.4.3 Saudi Arabia Market States and Outlook (2012-2022)
1.4.4.4 South Africa Market States and Outlook (2012-2022)
1.4.4.5 Nigeria Market States and Outlook (2012-2022)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Apotex Inc. (Canada)
2.1.1 Business Overview
2.1.2 Iron Chelation Drug Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 Apotex Inc. (Canada) Iron Chelation Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Cipla (India)
2.2.1 Business Overview
2.2.2 Iron Chelation Drug Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 Cipla (India) Iron Chelation Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Novartis (Switzerland)
2.3.1 Business Overview
2.3.2 Iron Chelation Drug Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 Novartis (Switzerland) Iron Chelation Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Sun Pharma (India)
2.4.1 Business Overview
2.4.2 Iron Chelation Drug Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 Sun Pharma (India) Iron Chelation Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Natco Pharma (India)
2.5.1 Business Overview
2.5.2 Iron Chelation Drug Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 Natco Pharma (India) Iron Chelation Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Iron Chelation Drug Market Competition, by Manufacturer
3.1 Global Iron Chelation Drug Sales and Market Share by Manufacturer
3.2 Global Iron Chelation Drug Revenue and Market Share by Manufacturer
3.3 Market Concentration Rate
3.3.1 Top 3 Iron Chelation Drug Manufacturer Market Share
3.3.2 Top 6 Iron Chelation Drug Manufacturer Market Share
3.4 Market Competition Trend
4 Global Iron Chelation Drug Market Analysis by Regions
4.1 Global Iron Chelation Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Iron Chelation Drug Sales by Regions (2012-2017)
4.1.2 Global Iron Chelation Drug Revenue by Regions (2012-2017)
4.2 North America Iron Chelation Drug Sales and Growth (2012-2017)
4.3 Europe Iron Chelation Drug Sales and Growth (2012-2017)
4.4 Asia-Pacific Iron Chelation Drug Sales and Growth (2012-2017)
4.5 South America Iron Chelation Drug Sales and Growth (2012-2017)
4.6 Middle East and Africa Iron Chelation Drug Sales and Growth (2012-2017)
5 North America Iron Chelation Drug by Countries
5.1 North America Iron Chelation Drug Sales, Revenue and Market Share by Countries
5.1.1 North America Iron Chelation Drug Sales by Countries (2012-2017)
5.1.2 North America Iron Chelation Drug Revenue by Countries (2012-2017)
5.2 USA Iron Chelation Drug Sales and Growth (2012-2017)
5.3 Canada Iron Chelation Drug Sales and Growth (2012-2017)
5.4 Mexico Iron Chelation Drug Sales and Growth (2012-2017)
6 Europe Iron Chelation Drug by Countries
6.1 Europe Iron Chelation Drug Sales, Revenue and Market Share by Countries
6.1.1 Europe Iron Chelation Drug Sales by Countries (2012-2017)
6.1.2 Europe Iron Chelation Drug Revenue by Countries (2012-2017)
6.2 Germany Iron Chelation Drug Sales and Growth (2012-2017)
6.3 UK Iron Chelation Drug Sales and Growth (2012-2017)
6.4 France Iron Chelation Drug Sales and Growth (2012-2017)
6.5 Russia Iron Chelation Drug Sales and Growth (2012-2017)
6.6 Italy Iron Chelation Drug Sales and Growth (2012-2017)
7 Asia-Pacific Iron Chelation Drug by Countries
7.1 Asia-Pacific Iron Chelation Drug Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Iron Chelation Drug Sales by Countries (2012-2017)
7.1.2 Asia-Pacific Iron Chelation Drug Revenue by Countries (2012-2017)
7.2 China Iron Chelation Drug Sales and Growth (2012-2017)
7.3 Japan Iron Chelation Drug Sales and Growth (2012-2017)
7.4 Korea Iron Chelation Drug Sales and Growth (2012-2017)
7.5 India Iron Chelation Drug Sales and Growth (2012-2017)
7.6 Southeast Asia Iron Chelation Drug Sales and Growth (2012-2017)
8 South America Iron Chelation Drug by Countries
8.1 South America Iron Chelation Drug Sales, Revenue and Market Share by Countries
8.1.1 South America Iron Chelation Drug Sales by Countries (2012-2017)
8.1.2 South America Iron Chelation Drug Revenue by Countries (2012-2017)
8.2 Brazil Iron Chelation Drug Sales and Growth (2012-2017)
8.3 Argentina Iron Chelation Drug Sales and Growth (2012-2017)
8.4 Columbia Iron Chelation Drug Sales and Growth (2012-2017)
9 Middle East and Africa Iron Chelation Drug by Countries
9.1 Middle East and Africa Iron Chelation Drug Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Iron Chelation Drug Sales by Countries (2012-2017)
9.1.2 Middle East and Africa Iron Chelation Drug Revenue by Countries (2012-2017)
9.2 Saudi Arabia Iron Chelation Drug Sales and Growth (2012-2017)
9.3 UAE Iron Chelation Drug Sales and Growth (2012-2017)
9.4 Egypt Iron Chelation Drug Sales and Growth (2012-2017)
9.5 Nigeria Iron Chelation Drug Sales and Growth (2012-2017)
9.6 South Africa Iron Chelation Drug Sales and Growth (2012-2017)
10 Global Iron Chelation Drug Market Segment by Type
10.1 Global Iron Chelation Drug Sales, Revenue and Market Share by Type (2012-2017)
10.1.1 Global Iron Chelation Drug Sales and Market Share by Type (2012-2017)
10.1.2 Global Iron Chelation Drug Revenue and Market Share by Type (2012-2017)
10.2 Deferoxamine Sales Growth and Price
10.2.1 Global Deferoxamine Sales Growth (2012-2017)
10.2.2 Global Deferoxamine Price (2012-2017)
10.3 Deferiprone Sales Growth and Price
10.3.1 Global Deferiprone Sales Growth (2012-2017)
10.3.2 Global Deferiprone Price (2012-2017)
10.4 Deferasirox Sales Growth and Price
10.4.1 Global Deferasirox Sales Growth (2012-2017)
10.4.2 Global Deferasirox Price (2012-2017)
11 Global Iron Chelation Drug Market Segment by Application
11.1 Global Iron Chelation Drug Sales Market Share by Application (2012-2017)
11.2 Transfusional Iron Overload Sales Growth (2012-2017)
11.3 NTDT Caused Iron Overload Sales Growth (2012-2017)
12 Iron Chelation Drug Market Forecast (2017-2022)
12.1 Global Iron Chelation Drug Sales, Revenue and Growth Rate (2017-2022)
12.2 Iron Chelation Drug Market Forecast by Regions (2017-2022)
12.2.1 North America Iron Chelation Drug Market Forecast (2017-2022)
12.2.2 Europe Iron Chelation Drug Market Forecast (2017-2022)
12.2.3 Asia-Pacific Iron Chelation Drug Market Forecast (2017-2022)
12.2.4 South America Iron Chelation Drug Market Forecast (2017-2022)
12.2.5 Middle East and Africa Iron Chelation Drug Market Forecast (2017-2022)
12.3 Iron Chelation Drug Market Forecast by Type (2017-2022)
12.4 Iron Chelation Drug Market Forecast by Application (2017-2022)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Analyst Introduction
15.3 Data Source

List of Tables and Figures

Figure Iron Chelation Drug Picture
Table Product Specifications of Iron Chelation Drug
Figure Global Sales Market Share of Iron Chelation Drug by Types in 2016
Table Iron Chelation Drug Types for Major Manufacturers
Figure Deferoxamine Picture
Figure Deferiprone Picture
Figure Deferasirox Picture
Table Iron Chelation Drug Sales Market Share by Applications in 2016
Figure Transfusional Iron Overload Picture
Figure NTDT Caused Iron Overload Picture
Figure USA Iron Chelation Drug Revenue (Value) and Growth Rate (2012-2022)
Figure Canada Iron Chelation Drug Revenue (Value) and Growth Rate (2012-2022)
Figure Mexico Iron Chelation Drug Revenue (Value) and Growth Rate (2012-2022)
Figure Germany Iron Chelation Drug Revenue (Value) and Growth Rate (2012-2022)
Figure France Iron Chelation Drug Revenue (Value) and Growth Rate (2012-2022)
Figure UK Iron Chelation Drug Revenue (Value) and Growth Rate (2012-2022)
Figure Russia Iron Chelation Drug Revenue (Value) and Growth Rate (2012-2022)
Figure Italy Iron Chelation Drug Revenue (Value) and Growth Rate (2012-2022)
Figure China Iron Chelation Drug Revenue (Value) and Growth Rate (2012-2022)
Figure Japan Iron Chelation Drug Revenue (Value) and Growth Rate (2012-2022)
Figure Korea Iron Chelation Drug Revenue (Value) and Growth Rate (2012-2022)
Figure India Iron Chelation Drug Revenue (Value) and Growth Rate (2012-2022)
Figure Southeast Asia Iron Chelation Drug Revenue (Value) and Growth Rate (2012-2022)
Figure Brazil Iron Chelation Drug Revenue (Value) and Growth Rate (2012-2022)
Figure Egypt Iron Chelation Drug Revenue (Value) and Growth Rate (2012-2022)
Figure Saudi Arabia Iron Chelation Drug Revenue (Value) and Growth Rate (2012-2022)
Figure South Africa Iron Chelation Drug Revenue (Value) and Growth Rate (2012-2022)
Figure Nigeria Iron Chelation Drug Revenue (Value) and Growth Rate (2012-2022)
Table Apotex Inc. (Canada) Basic Information, Manufacturing Base and Competitors
Table Apotex Inc. (Canada) Iron Chelation Drug Type and Applications
Table Apotex Inc. (Canada) Iron Chelation Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Cipla (India) Basic Information, Manufacturing Base and Competitors
Table Cipla (India) Iron Chelation Drug Type and Applications
Table Cipla (India) Iron Chelation Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis (Switzerland) Basic Information, Manufacturing Base and Competitors
Table Novartis (Switzerland) Iron Chelation Drug Type and Applications
Table Novartis (Switzerland) Iron Chelation Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Sun Pharma (India) Basic Information, Manufacturing Base and Competitors
Table Sun Pharma (India) Iron Chelation Drug Type and Applications
Table Sun Pharma (India) Iron Chelation Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Natco Pharma (India) Basic Information, Manufacturing Base and Competitors
Table Natco Pharma (India) Iron Chelation Drug Type and Applications
Table Natco Pharma (India) Iron Chelation Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Iron Chelation Drug Sales by Manufacturer (2016-2017)
Figure Global Iron Chelation Drug Sales Market Share by Manufacturer in 2016
Figure Global Iron Chelation Drug Sales Market Share by Manufacturer in 2017
Table Global Iron Chelation Drug Revenue by Manufacturer (2016-2017)
Figure Global Iron Chelation Drug Revenue Market Share by Manufacturer in 2016
Figure Global Iron Chelation Drug Revenue Market Share by Manufacturer in 2017
Figure Global Iron Chelation Drug Sales and Growth (2012-2017)
Figure Global Iron Chelation Drug Revenue and Growth (2012-2017)
Table Global Iron Chelation Drug Sales by Regions (2012-2017)
Table Global Iron Chelation Drug Sales Market Share by Regions (2012-2017)
Table Global Iron Chelation Drug Revenue by Regions (2012-2017)
Table Global Iron Chelation Drug Revenue Market Share by Regions in 2012
Table Global Iron Chelation Drug Revenue Market Share by Regions in 2016
Figure North America Iron Chelation Drug Sales and Growth (2012-2017)
Figure Europe Iron Chelation Drug Sales and Growth (2012-2017)
Figure Asia-Pacific Iron Chelation Drug Sales and Growth (2012-2017)
Figure South America Iron Chelation Drug Sales and Growth (2012-2017)
Figure Middle East and Africa Iron Chelation Drug Sales and Growth (2012-2017)
Figure North America Iron Chelation Drug Revenue and Growth (2012-2017)
Table North America Iron Chelation Drug Sales by Countries (2012-2017)
Table North America Iron Chelation Drug Sales Market Share by Countries (2012-2017)
Figure North America Iron Chelation Drug Sales Market Share by Countries in 2012
Figure North America Iron Chelation Drug Sales Market Share by Countries in 2016
Table North America Iron Chelation Drug Revenue by Countries (2012-2017)
Table North America Iron Chelation Drug Revenue Market Share by Countries (2012-2017)
Figure North America Iron Chelation Drug Revenue Market Share by Countries in 2012
Figure North America Iron Chelation Drug Revenue Market Share by Countries in 2016
Figure USA Iron Chelation Drug Sales and Growth (2012-2017)
Figure Canada Iron Chelation Drug Sales and Growth (2012-2017)
Figure Mexico Iron Chelation Drug Sales and Growth (2012-2017)
Figure Europe Iron Chelation Drug Revenue and Growth (2012-2017)
Table Europe Iron Chelation Drug Sales by Countries (2012-2017)
Table Europe Iron Chelation Drug Sales Market Share by Countries (2012-2017)
Table Europe Iron Chelation Drug Revenue by Countries (2012-2017)
Table Europe Iron Chelation Drug Revenue Market Share by Countries in 2012
Table Europe Iron Chelation Drug Revenue Market Share by Countries in 2016
Figure Germany Iron Chelation Drug Sales and Growth (2012-2017)
Figure UK Iron Chelation Drug Sales and Growth (2012-2017)
Figure France Iron Chelation Drug Sales and Growth (2012-2017)
Figure Russia Iron Chelation Drug Sales and Growth (2012-2017)
Figure Italy Iron Chelation Drug Sales and Growth (2012-2017)
Figure Asia-Pacific Iron Chelation Drug Revenue and Growth (2012-2017)
Table Asia-Pacific Iron Chelation Drug Sales by Countries (2012-2017)
Table Asia-Pacific Iron Chelation Drug Sales Market Share by Countries (2012-2017)
Table Asia-Pacific Iron Chelation Drug Sales Market Share by Countries (2012-2017)
Table Asia-Pacific Iron Chelation Drug Revenue by Countries (2012-2017)
Table Asia-Pacific Iron Chelation Drug Revenue Market Share by Countries (2012-2017)
Figure China Iron Chelation Drug Sales and Growth (2012-2017)
Figure Japan Iron Chelation Drug Sales and Growth (2012-2017)
Figure Korea Iron Chelation Drug Sales and Growth (2012-2017)
Figure India Iron Chelation Drug Sales and Growth (2012-2017)
Figure Southeast Asia Iron Chelation Drug Sales and Growth (2012-2017)
Figure South America Iron Chelation Drug Revenue and Growth (2012-2017)
Table South America Iron Chelation Drug Sales by Countries (2012-2017)
Table South America Iron Chelation Drug Sales Market Share by Countries (2012-2017)
Figure South America Iron Chelation Drug Sales Market Share by Countries in 2016
Table South America Iron Chelation Drug Revenue by Countries (2012-2017)
Table South America Iron Chelation Drug Revenue Market Share by Countries (2012-2017)
Figure South America Iron Chelation Drug Revenue Market Share by Countries in 2012
Figure South America Iron Chelation Drug Revenue Market Share by Countries in 2016
Figure Brazil Iron Chelation Drug Sales and Growth (2012-2017)
Figure Argentina Iron Chelation Drug Sales and Growth (2012-2017)
Figure Columbia Iron Chelation Drug Sales and Growth (2012-2017)
Figure Middle East and Africa Iron Chelation Drug Revenue and Growth (2012-2017)
Table Middle East and Africa Iron Chelation Drug Sales by Countries (2012-2017)
Table Middle East and Africa Iron Chelation Drug Sales Market Share by Countries (2012-2017)
Figure Middle East and Africa Iron Chelation Drug Sales Market Share by Countries in 2016
Table Middle East and Africa Iron Chelation Drug Revenue by Countries (2012-2017)
Table Middle East and Africa Iron Chelation Drug Revenue Market Share by Countries (2012-2017)
Figure Middle East and Africa Iron Chelation Drug Revenue Market Share by Countries in 2012
Figure Middle East and Africa Iron Chelation Drug Revenue Market Share by Countries in 2016
Figure Saudi Arabia Iron Chelation Drug Sales and Growth (2012-2017)
Figure UAE Iron Chelation Drug Sales and Growth (2012-2017)
Figure Egypt Iron Chelation Drug Sales and Growth (2012-2017)
Figure Nigeria Iron Chelation Drug Sales and Growth (2012-2017)
Figure South Africa Iron Chelation Drug Sales and Growth (2012-2017)
Table Global Iron Chelation Drug Sales by Type (2012-2017)
Table Global Iron Chelation Drug Sales Share by Type (2012-2017)
Table Global Iron Chelation Drug Revenue by Type (2012-2017)
Table Global Iron Chelation Drug Revenue Share by Type (2012-2017)
Figure Global Deferoxamine Sales Growth (2012-2017)
Figure Global Deferoxamine Price (2012-2017)
Figure Global Deferiprone Sales Growth (2012-2017)
Figure Global Deferiprone Price (2012-2017)
Figure Global Deferasirox Sales Growth (2012-2017)
Figure Global Deferasirox Price (2012-2017)
Table Global Iron Chelation Drug Sales by Application (2012-2017)
Table Global Iron Chelation Drug Sales Share by Application (2012-2017)
Figure Global Transfusional Iron Overload Sales Growth (2012-2017)
Figure Global NTDT Caused Iron Overload Sales Growth (2012-2017)
Figure Global Iron Chelation Drug Sales, Revenue and Growth Rate (2017 -2022)
Table Global Iron Chelation Drug Sales Forecast by Regions (2017-2022)
Table Global Iron Chelation Drug Market Share Forecast by Regions (2017-2022)
Figure North America Sales Iron Chelation Drug Market Forecast (2017-2022)
Figure Europe Sales Iron Chelation Drug Market Forecast (2017-2022)
Figure Asia-Pacific Sales Iron Chelation Drug Market Forecast (2017-2022)
Figure South America Sales Iron Chelation Drug Market Forecast (2017-2022)
Figure Middle East and Africa Sales Iron Chelation Drug Market Forecast (2017-2022)
Table Global Iron Chelation Drug Sales Forecast by Type (2017-2022)
Table Global Iron Chelation Drug Market Share Forecast by Type (2017-2022)
Table Global Iron Chelation Drug Sales Forecast by Application (2017-2022)
Table Global Iron Chelation Drug Market Share Forecast by Application (2017-2022)
Table Distributors/Traders/ Dealers List

【レポートのキーワード】

鉄キレート薬、デフェロキサミン、デフェリプロン、デフェラシロクス、輸血鉄過剰症、輸血非依存性サラセミア(NTDT)による鉄過剰症

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 鉄キレート薬の世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2022)(Global Iron Chelation Drug Market by Manufacturers, Countries, Type and Application, Forecast to 2022)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆